Grossprofit percentage is expected to be in the range of 42.0% to 44.0%, reflecting a higher mix of branded sales volume and the launch of new products, together with a significant reduction in the private label business.
The Roundup business has been a problem for a while, and Monsanto said growth in 2011 is expected to come exclusively from its seeds and genomics segment, where grossprofit is anticipated to grow in the double digits.